Viewing StudyNCT03393520

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 10:56 AM
Last Modification Date: 2024-10-26 @ 12:38 PM
Study NCT ID: NCT03393520
Status: COMPLETED
Last Update Posted: 2024-04-04
First Post: 2018-01-03
Brief Title: Assessment of the Efficacy Safety and Tolerability of AVP-786 Deudextromethorphan Hydrobromide d6-DMQuinidine Sulfate Q for the Treatment of Agitation in Patients With Dementia of the Alzheimers Type
Sponsor: Otsuka Pharmaceutical Development Commercialization Inc
Organization: Otsuka Pharmaceutical Development Commercialization Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Organization Data

Organization: Otsuka Pharmaceutical Development Commercialization Inc
Class: INDUSTRY
Study ID: 17-AVP-786-305
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Otsuka Pharmaceutical Development Commercialization Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators